Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The global ADC contract manufacturing market was valued at USD 12.51 Million in 2025, driven by the rising prevalence of cancer across the globe. The market is expected to grow at a CAGR of 12.70% during the forecast period of 2026-2035, with the values likely to reach USD 41.35 Million by 2035.
Key Market Trends and Insights
- The demand for ADCs is rising with increasing cancer prevalence worldwide. ADCs are in great demand due to their specificity in destroying cancer cells while preserving healthy tissues. Pharmaceutical companies are heavily investing in the production of ADCs as cancer is one of the leading causes of death.
- ADC technologies are evolving to enhance the medication’s safety, stability, and efficacy profiles. Improvements like this reduce adverse effects and boost uptake among medical practitioners.
- Due to their lack of infrastructure, many biopharmaceutical companies would rather outsource their large-scale ADC production. Contract manufacturing organizations (CMOs) provide facilities, regulatory compliance, and specialized knowledge. With the rise of outsourcing, businesses can concentrate on R&D while CMOs manage production which is expected to propel the market during the forecast period.
Market Size and Forecast
- Market Size in 2025: USD 12.51 Million
- Projected Market Size in 2035: USD 41.35 Million
- Compound Annual Growth Rate (CAGR) of 2026 to 2035: 12.70%
Compound Annual Growth Rate
12.7%
Value in USD Million
2026-2035
ADC Contract Manufacturing Market Overview
ADC contract manufacturing organizations (CMOs) manage intricate procedures like conjugation, drug payload synthesis, and antibody production, guaranteeing that ADCs are produced to exact specifications. By using external facilities and expertise for large-scale production, this service helps pharmaceutical companies cut costs and accelerate time-to-market. To meet both commercial and regulatory demands, companies without internal capabilities must use ADC contract manufacturing.
The market is primarily aided by the growing number of regulatory approvals for ADCs granted by agencies such as the FDA and EMA. Simplified approval procedures for ADCs promote more development because of their potential to fill medical needs that aren't being met. Businesses are investing in ADCs with greater assurance as regulations become more favourable and clearer. Hence, driving the business opportunity for ADC contract manufacturing.
ADC Contract Manufacturing Market Growth Drivers
Rising Investments in Biotechnology to Drive Market Growth
The market growth is accelerated by increased funding for biotechnology and ADC-related research from the public and private sectors. Innovation in biopharmaceutics encourages the creation of new ADC products and production capacities. This capital inflow helps established businesses as well as startups grow their ADC pipelines, thereby, bolstering the market's growth during the forecast period.
ADCs Contract Manufacturing Market Trends
Simtra BioPharma Solutions acquired a 65-acre property in Bloomington, Indiana, in July 2025 to evaluate a major expansion of its existing injectable manufacturing operations. The company plans to develop manufacturing lines focused on commercial-scale oncology medicines, with antibody-drug conjugates (ADCs) identified as a key opportunity. If completed, the project could position Simtra as one of the first U.S. CDMOs offering commercial-scale ADC drug-product manufacturing. The planned facility is expected to incorporate isolator-based vial and prefilled-syringe lines, strengthening Simtra’s ability to provide specialised sterile fill-finish services for complex oncology products.
Swiss CDMO Carbogen AMCIS announced in June 2025 that it and a Japanese partner would invest CHF 25.5 million (approximately US$31 million) to upgrade two Swiss facilities for commercial production of ADC linkers. The investment covers its Aarau and Neuland sites, with new 850-litre reactors and agitated filter dryers planned. Aarau is targeted for ADC production in the first quarter of 2027, while the Neuland upgrade is expected in the third quarter of 2027. The project strengthens Carbogen’s position in the specialised linker segment and expands CDMO capacity for the increasingly complex ADC supply chain.
MilliporeSigma and Simtra BioPharma Solutions announced a five-year partnership in June 2025 to provide a more integrated ADC manufacturing service. Under the arrangement, MilliporeSigma handles bioconjugation at its St. Louis facility and can manufacture highly potent payloads at its Madison, Wisconsin site, while Simtra manages drug-product formulation and fill-finish. The companies also coordinate analytical activities. The partnership addresses the complex, multi-stage nature of ADC production by combining specialised capabilities across the value chain. For pharmaceutical developers, this model can reduce the need to coordinate multiple suppliers for conjugation, formulation and sterile manufacturing, thereby bolstering the ADC contract manufacturing market growth.
LOTTE BIOLOGICS announced in April 2025 that it had signed its first manufacturing agreement for a clinical-stage ADC candidate from an Asia-based biotechnology company, marking the full-scale launch of its ADC CDMO business. Its dedicated Syracuse, New York facility was developed with approximately US$100 million invested in ADC capabilities. The cGMP facility provides integrated production and purification, including a conjugation reactor with capacity of up to 1,000 litres, in-house quality control and advanced characterisation. The facility also incorporates single-use technology and automated aseptic filling, supporting ADC development from antibody preprocessing through drug-substance manufacturing and conjugation.
Commercial-Scale ADC Manufacturing Is Expanding in the United States
ADC contract manufacturers are expanding into more specialized and larger plants that are geared toward the move of ADCs from development into commercial manufacture. This is seen from the expansion plan of Simtra BioPharma Solutions in Bloomington, Indiana, where there are plans for isolator-based vial and pre-filled syringe lines for oncology products. In addition to being able to handle potent materials, a commercial-scale operation must have the capacity to maintain sterility and containment while ensuring consistent product quality. The development of specialized capacity within the U.S. may even allow companies to lessen dependence on offshore manufacturing. As more ADC candidates approach approval, CDMOs with validated commercial drug-product capabilities are likely to gain a competitive advantage in the market.
ADC Linker Manufacturing Is Becoming More Industrialised
The ADC contract manufacturing industry is witnessing a rise in investment towards specialized linker production due to the complex nature of their supply chain. The upgrade planned by Carbogen AMCIS in Switzerland includes bigger reactors and agitated filter dryers to manufacture linkers on a commercial scale. Linkers should be stable enough in circulation but at the same time facilitate efficient payload liberation within targeted cells, which makes their manufacture quite a technical challenge. Having bigger and dedicated equipment for manufacturing could enhance process reliability and economic efficiency of the manufacturing process. This trend indicates that CDMOs are moving beyond small-scale development services and building robust infrastructure for commercial linker supply, supporting the expanding pipeline of next-generation ADC therapies, thus bolstering the ADC contract manufacturing demand.
Integrated End-to-End ADC Manufacturing Is Gaining Importance
ADC developers increasingly prefer CDMO partners capable of coordinating multiple manufacturing stages through a single integrated service. The MilliporeSigma–Simtra partnership combines payload production, bioconjugation, formulation, analytical support and sterile fill-finish across specialised facilities. This model addresses a major technical challenge: ADC manufacturing involves highly potent payloads, complex conjugation chemistry and demanding aseptic processing. Integrated services can reduce technology-transfer risks, simplify project management and improve communication between process-development teams. They may also shorten development timelines by limiting the number of external handoffs. As ADC programmes become more complex, end-to-end manufacturing platforms are likely to become an important differentiator among competing CDMOs.
Single-Use and Automated Technologies Are Advancing ADC Production
Single-use equipment and automation of the filling process and advanced containment technologies are being implemented by ADC CDMOs in order to increase flexibility, ensure safety and better process control. The LOTTE BIOLOGICS’ Syracuse site utilises single-use equipment and automated aseptic filling in combination with purification and advanced characterisation processes. These technologies may help decrease the need for cleaning, minimise the risk of cross-contamination and increase flexibility due to faster changeovers. Moreover, automation ensures better reproducibility of the process during the filling and packaging of high-value and highly potent oncology drugs. As ADC portfolios expand and batch sizes vary between clinical and commercial programmes, flexible single-use systems can help manufacturers manage multiple products while maintaining stringent quality and containment standards, hence augmenting the ADC contract manufacturing market trends and dynamics.
High-Containment Technologies Are Becoming Central to ADC CDMOs
The increasing potency of ADC payloads is driving investment in advanced containment, closed processing and specialised sterile manufacturing technologies. Facilities must protect operators and the environment while preventing cross-contamination between products. Isolator-based filling lines, contained reactors, dedicated handling systems and sophisticated analytical controls are therefore becoming essential components of ADC manufacturing infrastructure. Simtra’s planned isolator-based lines and LOTTE BIOLOGICS’ dedicated conjugation capabilities reflect this technological direction. High-containment manufacturing also requires specialised training, validated cleaning strategies and robust occupational-safety procedures. CDMOs that can combine potent-compound handling with reliable aseptic processing will be better positioned to support complex ADC programmes.
ADC Contract Manufacturing Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Linker
- Cleavable Linker
- Non-Cleavable Linker
Market Breakup by Application
- Myeloma
- Lymphoma
- Breast Cancer
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
ADC Contract Manufacturing Market Share
The Cleavable Segment Holds a Significant Market Share
The market segmentation by linker is divided into cleavable linker and non-cleavable linker. Precise delivery is ensured by cleavable linkers in ADCs, which are chemical bonds that release the drug payload inside target cancer cells. These intricate linkers, which need to be produced with extreme precision for efficient drug release, are the specialty of ADC contract manufacturers. Consequently, cleavable linkers are expected to lead the market share in the forecast period.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
ADC Contract Manufacturing Market Analysis by Region
Regionally, North America is expected to dominate the market during the forecast period. This can primarily be ascribed to the rise in the prevalence of cancer and autoimmune diseases along with the growth in the geriatric population in the region. The United States dominated the market in North America in 2021 owing to factors such as a high patient pool for major chronic diseases. Additionally, over the forecast period, the presence of major players, early adoption of technologically advanced products, and an increase in research and development activities are expected to propel regional growth in the market.
Leading Players in the Global ADC Contract Manufacturing Market
The key features of the market report comprise the patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Samsung Biologics
Founded in 2011, Samsung Biologics is a top contract development and manufacturing organization (CDMO) with a focus on biopharmaceuticals, with its headquarters located in Incheon, South Korea. The company uses cutting-edge facilities and biologics knowledge to provide a wide range of services, including ADC contract manufacturing. It provides end-to-end solutions from development to commercial-scale production, which benefits multinational pharmaceutical companies.
Lonza
It is a global leader in contract manufacturing and development services, with a focus on biologics, including ADCs. It was founded in 1897 and has its headquarters in Basel, Switzerland. The business provides comprehensive ADC production solutions that address large-scale manufacturing, conjugation, and drug development. With its state-of-the-art technologies and knowledge, Lonza helps biopharma companies effectively bring sophisticated ADC therapies to market.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Catalent, Inc., Siegfried Holding AG, Piramal Pharma Limited, Sartorius AG, WuXi Biologics, and Sterling Pharma Solutions Limited (PMDO) among others.
Key Questions Answered in the ADC Contract Manufacturing Market Report
- What was the global ADC contract manufacturing market value in 2025?
- What is the global ADC contract manufacturing market forecast outlook for 2026-2035?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on linker?
- What is the market breakup based on application?
- What are the major factors aiding the global ADC contract manufacturing market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the prevalence and incidence of chronic diseases affect the market landscape?
- What are the major global ADC contract manufacturing market trends?
- How does the rise in the geriatric population impact the market size?
- Which product type will dominate the market share?
- Which application is expected to have a high market value in the coming years?
- Which end user is projected to contribute to the highest market growth?
- Who are the key players involved in the ADC contract manufacturing market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
More Insights on
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Linker |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
